ConductScience.org, home

Paper39286181

Therapeutic effect of fenugreek supplementation on type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials.

Vajdi M and 7 others. Heliyon, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic effect of fenugreek supplementation on type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials. Papers, record 39286181. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39286181

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic effect of fenugreek supplementation on type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials.
PubMed
Journal
Heliyon
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.81, provisional
iCite
Revised in PubMed
2024-09-18
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vajdi MMahdi
2Noshadi NNooshin
3Bonyadian AAtefeh
4Golpour-Hamedani SSahar
5Alipour BBeitullah
6Pourteymour Fard Tabrizi FFatemeh
7Abbasalizad-Farhangi MMahdieh
8Askari GGholamreza

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121208779GRADE guidelines: 3. Rating the quality of evidence.J Clin Epidemiol2011https://conductscience.org/library/papers/21208779PubMed
219622511Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.Ann Intern Med2009https://conductscience.org/library/papers/19622511PubMed
38457534The effect of an ethanol extract derived from fenugreek (Trigonella foenum-graecum) on bile acid absorption and cholesterol levels in rats.Br J Nutr1993https://conductscience.org/library/papers/8457534PubMed
49175175Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease.Prostaglandins Leukot Essent Fatty Acids1997https://conductscience.org/library/papers/9175175PubMed
532385866Effect of fenugreek consumption on serum lipid profile: A systematic review and meta-analysis.Phytother Res2020https://conductscience.org/library/papers/32385866PubMed
620540147Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues.Mol Nutr Food Res2010https://conductscience.org/library/papers/20540147PubMed
734879977IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.Diabetes Res Clin Pract2022https://conductscience.org/library/papers/34879977PubMed
832550211Chromium Supplementation; Negotiation with Diabetes Mellitus, Hyperlipidemia and Depression.J Diabetes Metab Disord2020https://conductscience.org/library/papers/32550211PubMed
936992660Effect of saffron and fenugreek on lowering blood glucose: A systematic review with meta-analysis.Phytother Res2023https://conductscience.org/library/papers/36992660PubMed
1016807131Random-effects model for meta-analysis of clinical trials: an update.Contemp Clin Trials2007https://conductscience.org/library/papers/16807131PubMed
1136470549Effects of fenugreek supplementation on the components of metabolic syndrome: A systematic review and dose-response meta-analysis of randomized clinical trials.Pharmacol Res2023https://conductscience.org/library/papers/36470549PubMed
1218219452Clinical observation on trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus.Chin J Integr Med2008https://conductscience.org/library/papers/18219452PubMed
1332147060The effect of fenugreek seed supplementation on serum irisin levels, blood pressure, and liver and kidney function in patients with type 2 diabetes mellitus: A parallel randomized clinical trial.Complement Ther Med2020https://conductscience.org/library/papers/32147060PubMed
1421617109Globalization of diabetes: the role of diet, lifestyle, and genes.Diabetes Care2011https://conductscience.org/library/papers/21617109PubMed
1537459747A Placebo-Controlled, Double-Blind Clinical Investigation to Evaluate the Efficacy of a Patented Trigonella foenum-graecum Seed Extract "Fenfuro®" in Type 2 Diabetics.J Am Nutr Assoc2024https://conductscience.org/library/papers/37459747PubMed
1615840177Estimating the mean and variance from the median, range, and the size of a sample.BMC Med Res Methodol2005https://conductscience.org/library/papers/15840177PubMed
1725922446A Review on Ethnobotanical and Therapeutic Uses of Fenugreek (Trigonella foenum-graceum L).J Evid Based Complementary Altern Med2016https://conductscience.org/library/papers/25922446PubMed
1832087319Effect of fenugreek supplementation on blood lipids and body weight: A systematic review and meta-analysis of randomized controlled trials.J Ethnopharmacol2020https://conductscience.org/library/papers/32087319PubMed
1934181914Treatment of type 2 diabetes: challenges, hopes, and anticipated successes.Lancet Diabetes Endocrinol2021https://conductscience.org/library/papers/34181914PubMed
209310563Bias in meta-analysis detected by a simple, graphical test.BMJ1997https://conductscience.org/library/papers/9310563PubMed

See all 46 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42942889Natural Products in Diabetes Mellitus: A Narrative Review of Mechanistic Insights into Metabolic Regulation and Therapeutic Potential.Nutrients2026https://conductscience.org/library/papers/42942889PubMed
42618886Combined Supplementation With Trigonella foenum-graecum and Nigella sativa Seed Powders Improves Glycemic Control, Dyslipidemia, and Organ Function in Alloxan-Induced Diabetic Rats.J Food Sci2026https://conductscience.org/library/papers/42618886PubMed
40006091Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40006091PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39286181

GET https://conductscience.org/api/papers/v1/39286181/references?page=2